287 related articles for article (PubMed ID: 28396716)
1. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.
Brivio S; Cadamuro M; Strazzabosco M; Fabris L
World J Hepatol; 2017 Mar; 9(9):455-468. PubMed ID: 28396716
[TBL] [Abstract][Full Text] [Related]
2. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.
Cadamuro M; Stecca T; Brivio S; Mariotti V; Fiorotto R; Spirli C; Strazzabosco M; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1435-1443. PubMed ID: 28757170
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.
Cadamuro M; Morton SD; Strazzabosco M; Fabris L
Transl Gastrointest Cancer; 2013 Jul; 2(3):130-144. PubMed ID: 28989865
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
Brivio S; Cadamuro M; Fabris L; Strazzabosco M
J Clin Med; 2015 Dec; 4(12):2028-41. PubMed ID: 26703747
[TBL] [Abstract][Full Text] [Related]
5. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
Gentilini A; Pastore M; Marra F; Raggi C
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.
Brivio S; Cadamuro M; Fabris L; Strazzabosco M
Gene Expr; 2018 Mar; 18(1):31-50. PubMed ID: 29070148
[TBL] [Abstract][Full Text] [Related]
7. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.
Rimassa L; Personeni N; Aghemo A; Lleo A
J Autoimmun; 2019 Jun; 100():17-26. PubMed ID: 30862450
[TBL] [Abstract][Full Text] [Related]
8. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.
Clapéron A; Mergey M; Aoudjehane L; Ho-Bouldoires TH; Wendum D; Prignon A; Merabtene F; Firrincieli D; Desbois-Mouthon C; Scatton O; Conti F; Housset C; Fouassier L
Hepatology; 2013 Dec; 58(6):2001-11. PubMed ID: 23787814
[TBL] [Abstract][Full Text] [Related]
9. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
Vaquero J; Lobe C; Tahraoui S; Clapéron A; Mergey M; Merabtene F; Wendum D; Coulouarn C; Housset C; Desbois-Mouthon C; Praz F; Fouassier L
Clin Cancer Res; 2018 Sep; 24(17):4282-4296. PubMed ID: 29716918
[No Abstract] [Full Text] [Related]
10. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions.
Massani M; Stecca T; Fabris L; Caratozzolo E; Ruffolo C; Furlanetto A; Morton S; Cadamuro M; Strazzabosco M; Bassi N
Oncol Rep; 2013 Sep; 30(3):1143-8. PubMed ID: 23807641
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.
Vaquero J; Guedj N; Clapéron A; Nguyen Ho-Bouldoires TH; Paradis V; Fouassier L
J Hepatol; 2017 Feb; 66(2):424-441. PubMed ID: 27686679
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.
Roy S; Glaser S; Chakraborty S
Front Med (Lausanne); 2019; 6():293. PubMed ID: 31921870
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
16. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
Raggi C; Correnti M; Sica A; Andersen JB; Cardinale V; Alvaro D; Chiorino G; Forti E; Glaser S; Alpini G; Destro A; Sozio F; Di Tommaso L; Roncalli M; Banales JM; Coulouarn C; Bujanda L; Torzilli G; Invernizzi P
J Hepatol; 2017 Jan; 66(1):102-115. PubMed ID: 27593106
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.
Chan TS; Shaked Y; Tsai KK
Front Oncol; 2019; 9():688. PubMed ID: 31417869
[TBL] [Abstract][Full Text] [Related]
19. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.
Voigtländer T; Metzger J; Husi H; Kirstein MM; Pejchinovski M; Latosinska A; Frantzi M; Mullen W; Book T; Mischak H; Manns MP
J Biomed Sci; 2020 Jan; 27(1):13. PubMed ID: 31900160
[TBL] [Abstract][Full Text] [Related]
20. Modelling metastatic colonization of cholangiocarcinoma organoids in decellularized lung and lymph nodes.
van Tienderen GS; van Beek MEA; Schurink IJ; Rosmark O; Roest HP; Tieleman J; Demmers J; Muntz I; Conboy J; Westergren-Thorsson G; Koenderink G; van der Laan LJ; Verstegen MMA
Front Oncol; 2022; 12():1101901. PubMed ID: 36741736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
